As featured in Zepbound is FDA-approved tirzepatide from Eli Lilly the first dual-action GLP-1/GIP medication approved specifically for chronic weight management
But some side effects, particularly for women, can be concerning, including the loss of muscle mass
Brighter, more even skin tone: A randomized trial showed 500 mg/day reduced melanin in sun-exposed skin after 4 weeks
Diet alone is not a treatment for metabolic conditions, but it can meaningfully support appetite regulation alongside medical guidance
Healthcare providers typically balance the unknown risks of semaglutide against the known risks of untreated obesity during pregnancy when counseling patients
Big pharmaceutical companies, government regulators, and doctors have little power to intervene as people look to DIY their way into new bodies